Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Are these the FTSE 100’s ‘safest’ dividend stocks?

Royston Wild reveals four FTSE 100 (INDEXFTSE: UKX) giants with terrific payout prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at four FTSE 100 (INDEXFTSE: UKX) stocks with dynamite dividend potential.

Electrify your stocks portfolio

Network operator National Grid (LSE: NG) is possibly the most secure selection out there for those seeking dependable dividend growth year after year.

Electricity is one of those modern-world commodities we simply can’t live without. And National Grid has a stranglehold on power provision in the UK — the network operator doesn’t face the same competitive pressures as suppliers like Centrica or SSE.

As such, it enjoys the sort of earnings visibility most companies can only dream of, making it an exceptional ‘stress-free’ stock for income chasers. And a dividend yield of 4% for the year to March 2017 makes mincemeat of the blue chip average of 3.5%.

The perfect pill

Unlike National Grid, AstraZeneca (LSE: AZN) has been forced to trash its progressive dividend policy in recent years as patents expiring on key drugs have crushed earnings.

Still, a shareholder reward of 280 US cents per share locked for the past several years has created market-mashing yields. And the City expects dividends to remain at these levels until the close of 2017, creating a brilliant 4.4% yield.

The impact of further label losses is expected to keep earnings on the back foot right through to the end of next year, according to broker consensus.

Regardless, I believe AstraZeneca has the financial strength to meet these dividend projections until its pipeline of next-generation treatments can hit the shelves en masse in the coming years. Sales of new cancer battler Tagrisso came in at a brilliant $143m during January-June, for instance, and the Cambridge firm plans to pull plenty more revenue drivers out of the hat.

Safe as houses

Diversification is very much the name of the game for Bunzl (LSE: BNZL), a quality that has made it one of the Footsie’s most reliable earnings stocks for what now seems an age.

Bunzl supplies essential goods and services across a multitude of industries, and its presence can be found across supermarkets, warehouses, building sites, hospitals and all manner of other facilities across the globe.

This has protected earnings from turbulence in one or two sectors or territories and allowed Bunzl to lift the annual dividend for 23 years on the spin.

A dividend yield of 1.8% for 2016 may not set pulses racing. Still, I reckon Bunzl is one of the FTSE 100’s best bets for those seeking relentless dividend expansion.

Ring up a fortune

Despite the huge costs of its multibillion-pound Project Spring organic investment programme, Vodafone’s (LSE: VOD) ability to generate mind-boggling amounts of cash has enabled it to keep growing the dividend.

And while the telecoms play remains active on the M&A front, a winding down of infrastructure costs should provide Vodafone’s balance sheet with a welcome shot in the arm.

And investors can also take confidence from Vodafone’s improving sales outlook — organic service revenues advanced 2.2% during April-June as its European operations continued to improve and emerging market demand soared.

Vodafone sports a monster 5% yield for the period to March 2017. And I expect dividends to keep impressing in the years ahead as earnings flip higher.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca and Centrica. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Night Takeoff Of The American Space Shuttle
Investing Articles

4 dirt-cheap growth shares to consider for 2026!

Discover four top growth shares that could take off in the New Year -- and why our writer Royston Wild…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

I asked ChatGPT how to start investing in UK shares with just £500 and it said do this

Harvey Jones asks artificial intelligence a few questions about how to get started in investing, before giving up and deciding…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Dividend Shares

Yielding 10.41%, is this the best dividend share in the FTSE 250?

Jon Smith points out a dividend share with a double-digit yield, but explains why digging below the surface provides important…

Read more »

Investing Articles

Is 2026 the year it all goes wrong for the Rolls-Royce share price?

2025 has been another stellar year for the Rolls-Royce share price but Harvey Jones wonders just how long its magnificent…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

A SpaceX IPO could light a fire under this FTSE 100 stock

Shareholders of this FTSE 100 investment trust may have just got an early Christmas present from Space Exploration Technologies (SpaceX).

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

Can dividends REALLY provide a second income you can live on?

Achieving a strong and sustained passive income in retirement may be easier than you think, even as yields on UK…

Read more »

Market Movers

33p penny stock Made Tech could be set for huge gains in 2026, if City analysts are right

This penny stock just experienced a sharp move higher. However, analysts reckon that there are plenty more gains to come…

Read more »

Elevated view over city of London skyline
Investing Articles

FTSE shares: a simple way to build long-term wealth?

Christopher Ruane explains some factors he thinks an investor should consider when trying to build wealth by investing in FTSE…

Read more »